Simplified assessment tool

Multiple regions
Original Title
Simplified assessment tool
CDC - Centers for Disease Control and Prevention
Publication Year


This document provides a tool for conducting an assessment of a National Immunization Technical Advisory Group (NITAG) based on the WHO guidance  and partners’ field experience and inputs.
The tool is relevant for either a self-assessment or an externally conducted assessment. Countries may choose to use it at any point on the NITAG’s life cycle to systematically assess how the committee functions and advises on immunization policy. A NITAG may choose to use the tool soon after its establishment so it can plan and document processes that will improve the capacity of the NITAG. In some cases, a NITAG may decide to use the tool annually or after recommendations have been made to assess the extent to which the NITAG’s functionality, quality of work processes and integration facilitated or hampered the development of evidence-based recommendations. In this way, the assessment could serve as part of a quality improvement process. Another use of the tool could be prior to or as part of a larger immunization program review (e.g., EPI review, Gavi joint appraisal).


Related News & Events

  • Chile

    Chile's NITAG documents the results of the committee's evaluation


    In this article, we describe the structure, functioning and work processes of Chile’s NITAG (CAVEI) and assess its functionality, quality of work processes and outputs, and integration of the committee into the Ministry of Health policy process using the Assessment tool for National Immunization Technical Advisory Groups.

    Read more
  • NITAG training

    Read more on NITAG training in resource-constrained settings


    Antoinette Ba-Nguy and Adeel Shaah, ex-SIVAC staff and experienced NITAG trainers,  wrote an article on the NITAG trainings delivered through the Partnership for Influenza Vaccine Introduction (PIVI) program.

    Read more
  • SAGE

    new Interim Recommendations on Vaccination against Ebola Virus Disease from SAGE


    Over the last four weeks, the Ebola outbreak in the Eastern Provinces of the Democratic Republic of Congo (DRC) has deteriorated with a large increase in the number of cases1. A major factor in this rise is an increase in critical security incidents that have dramatically affected the ability to identify, follow up and vaccinate contacts successfully. This context challenges the implementation of ring vaccination based on the identification of contacts and contacts of contacts, as recommended by SAGE in April 2017 and confirmed by SAGE during its April 2019 meeting. Further, a potential vaccine shortage may manifest in case the outbreak expands further and/or is prolonged.

    Read more